Purpose To characterize the effects of benzalkonium chloride (BAK) in THP-1 differentiated
cells in vitro. Methods Macrophages were obtained after differentiation of THP-1 cells, a …

BACKGROUND: Blastic plasmacytoid dendritic cell neoplasm (BPDC) is a rare hematologic
neoplasm, which almost always involves the skin and shows poor prognosis. OBJECTIVE …

The concept of multi-targeted immunotherapeutic systems has propelled the field of cancer
immunotherapy into an exciting new era. Multi-effector molecules can be designed to …

BACKGROUND: Information about maturation of plasmacytoid dendritic cell precursors (pre‐
pDCs) in normal bone marrow (BM) remains limited. STUDY DESIGN AND METHODS …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy
with a poor prognosis. The normal counterpart of BPDCN has been proposed to be …

This atlas presents not only the differential diagnosis but also the detailed morphologic,
immunophenotypic, and especially genetic characteristics of the majority of hematolymphoid …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematologic
malignancy originating from the precursor of the plasmacytoid dendritic cell. It is very rare …

CD4+ CD56+ malignancies have only recently been related to dendritic cell (DC) lineage.
The few cases described, mostly adults and elderly, typically present with cutaneous lesions …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive myeloid malignancy
of the dendritic cell lineage that affects patients of all ages, though the incidence appears to …

The sialic acid-binding immunoglobulin (Ig)-type lectin (Siglec) CD33 is a cell surface
glycoprotein with elusive function (s) characterized by a membrane distal V-set and a …